Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Apr 24.
Published in final edited form as: JAMA Intern Med. 2013 Jul 8;173(13):1252–1257. doi: 10.1001/jamainternmed.2013.6057

Decision-Making Preferences Among Patients With An Acute Myocardial Infarction

Harlan M Krumholz 1, José Augusto Barreto-Filho 1, Philip G Jones 1, Yan Li 1, John A Spertus 1
PMCID: PMC4409122  NIHMSID: NIHMS678602  PMID: 23712775

TO THE EDITOR

Despite numerous calls for greater participation by patients in the medical decision-making process,1,2 shared decision-making is not yet integrated into routine medical care, perhaps because of a perception that patients wish to defer to their physicians. We sought to investigate preferences for participation in the decision-making process among individuals hospitalized with an acute myocardial infarction (AMI).

METHODS

We combined data from 2 similar AMI registries: Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status (TRIUMPH) and the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER). The studies, which have been previously described, had similar inclusion criteria and common enrollment sites.3,4 We collected, among other information, detailed data on clinical comorbidities, admission and discharge medications, presenting electrocardiogram, and treatments during the first 24 hours through chart abstraction. Trained hospital research staff administered interviews between 24 and 72 hours after admission.

We assessed patient shared decision-making preferences with the question, Given the information about risks and benefits of the possible treatments, who should decide which treatment option should be selected?.5 The response rate to the question was 96.6% (2,414 of 2,498) for PREMIER and 97.3% (4,222 of 4,340) for TRIUMPH. Patients responded on a 5-point Likert scale: 1=doctor alone, 2=mostly doctor, 3=doctor and you, 4=mostly you, 5=you alone. We dichotomized the response into 2 categories: passive (Likert scores 1 and 2) and active (3, 4, and 5). We compared the baseline characteristics of patients with and without a preference to be actively involved and developed a predictive model employing a hierarchical modified Poisson regression model, which adjusted for clustering at the hospital level. All tests for significance were 2-tailed with an α level of 0.05, and were conducted with SAS version 9.1.3 (SAS Institute Inc., Cary, NC) and R version 2.6.0 (Vienna, Austria).

RESULTS

Of 6,636 patients in the study sample, 4,536 (68%) desired active engagement in shared decision-making (Table). Among those, 2,735 (60.3%) indicated that the doctor and patient should participate equally, 696 (15.3%) indicated that the patient should predominantly determine the decision, and 1,105 (24.4%) said that the patient alone should determine it. For all patient characteristics, the majority (68%) preferred an active role in decision-making. Those who preferred an active role tended to be younger, but none of the age groups had less than a majority that preferred active engagement. Compared with patients who did not complete high school, patients who had a college degree and those with a graduate degree had a much greater likelihood of preferring an active approach. However, even among those with less than a high school education, 58% preferred an active style. Financial resources were not associated with preferences. In the multivariable model, we identified 7 variables with a significant and independent association with an active decision-making preference: women, white race, higher education, smoker, heart failure, lower GRACE risk score, and not undergoing PCI during the hospitalization. The discrimination of the final model was modest, with a c-statistic of 0.61.

Table.

Associations between patient characteristics and preferences.

Desire for decision-making role
Active (n=4536) Passive (n=2100) P-Value

Demographics
Age 59.0 ± 12.5 61.0 ± 12.8 <0.001
19 - <55 1745 (72.3%) 668 (27.7%) <0.001
55 - <65 1354 (67.3%) 659 (32.7%)
65 - <75 843 (67.0%) 415 (33.0%)
75 - 98 594 (62.4%) 358 (37.6%)
Sex 0.045
Male 3002 (67.6%) 1442 (32.4%)
Female 1534 (70.0%) 658 (30.0%)
Race <0.001
White/Caucasian 3247 (70.3%) 1373 (29.7%)
Black/African American 1028 (64.1%) 575 (35.9%)
Other 243 (62.5%) 146 (37.5%)
Unknown 18 6
Social and economic factors
Married 0.785
Yes 2446 (68.5%) 1123 (31.5%)
No 2076 (68.2%) 967 (31.8%)
Missing 14 10
Education <0.001
Less than high school 794 (57.5%) 588 (42.5%)
High school or some college/vocational school 2643 (68.9%) 1193 (31.1%)
College degree 666 (77.0%) 199 (23.0%)
Graduate degree 407 (79.8%) 103 (20.2%)
Missing 26 17
Payor <0.001
Commercial/Preferred Provider Organization 1850 (70.7%) 766 (29.3%)
Health Maintenance Organization 540 (70.9%) 222 (29.1%)
Medicare 861 (64.0%) 484 (36.0%)
Medicaid 236 (66.1%) 121 (33.9%)
Other 202 (68.5%) 93 (31.5%)
None/Self-pay 724 (66.4%) 367 (33.6%)
Missing 123 47
Work/pay status <0.001
Yes, I work full-time for pay 1788 (71.5%) 712 (28.5%)
Yes, I work part-time for pay 409 (68.4%) 189 (31.6%)
No, I don't currently work for pay 2306 (66.0%) 1186 (34.0%)
Missing 33 13
Avoidance of health care due to cost 0.472
Yes 1034 (69.2%) 461 (30.8%)
No 3441 (68.2%) 1606 (31.8%)
Missing 61 33
ENRICHD social support score 22.0 ± 4.4 21.8 ± 4.6 0.117
Missing 106 44
PHQ 8-item Depression Score 5.2 ± 5.2 5.4 ± 5.3 0.241
Missing 203 87
Having a primary care physician 0.267
None 445 (69.0%) 200 (31.0%)
Emergency 154 (63.6%) 88 (36.4%)
Other 3895 (68.5%) 1794 (31.5%)
Missing 42 18
Clinical factors
Hypercholesterolemia 0.760
Yes 2213 (68.2%) 1033 (31.8%)
No 2323 (68.5%) 1067 (31.5%)
Hypertension 0.055
Yes 2930 (67.6%) 1407 (32.4%)
No 1606 (69.9%) 693 (30.1%)
Peripheral arterial disease 0.379
Yes 252 (66.3%) 128 (33.7%)
No 4284 (68.5%) 1972 (31.5%)
Diabetes <0.001
Yes 1294 (65.4%) 685 (34.6%)
No 3242 (69.6%) 1415 (30.4%)
Chronic renal failure 0.424
Yes 385 (69.9%) 166 (30.1%)
No 4151 (68.2%) 1934 (31.8%)
Chronic lung disease 0.283
Yes 416 (66.5%) 210 (33.5%)
No 4120 (68.6%) 1890 (31.4%)
Congestive heart failure 0.184
Yes 428 (66.0%) 220 (34.0%)
No 4108 (68.6%) 1880 (31.4%)
Cancer (excluding skin cancer) 0.362
Yes 334 (66.5%) 168 (33.5%)
No 4202 (68.5%) 1932 (31.5%)
Smoking 0.125
Never 1043 (68.0%) 491 (32.0%)
In the past (<100 total) 247 (70.8%) 102 (29.2%)
Stopped >1 year ago 1339 (66.6%) 671 (33.4%)
Stopped 1 month to 1 year ago 164 (65.9%) 85 (34.1%)
Current (past 30 days) 1724 (69.9%) 743 (30.1%)
Missing 19 8
Body mass index 0.059
10 - <30 2530 (67.6%) 1214 (32.4%)
30 - 82 1766 (69.8%) 763 (30.2%)
Missing 240 123
Family history of coronary artery disease 0.001
Yes 2741 (70.0%) 1176 (30.0%)
No 1773 (66.2%) 907 (33.8%)
Missing 21 17
Unknown 1
Medication/counseling for depression 0.374
Yes 559 (69.8%) 242 (30.2%)
No 3945 (68.2%) 1837 (31.8%)
Missing 32 21
Clinical history
Angina 0.966
Yes 719 (68.4%) 332 (31.6%)
No 3817 (68.3%) 1768 (31.7%)
Acute myocardial infarction 0.016
Yes 923 (65.7%) 482 (34.3%)
No 3613 (69.1%) 1618 (30.9%)
Coronary artery bypass graft surgery 0.212
Yes 524 (66.4%) 265 (33.6%)
No 4012 (68.6%) 1835 (31.4%)
Percutaneous coronary intervention 0.085
Yes 835 (66.3%) 424 (33.7%)
No 3701 (68.8%) 1676 (31.2%)
Stroke <0.001
Yes 215 (58.9%) 150 (41.1%)
No 4321 (68.9%) 1950 (31.1%)
Severity of acute myocardial infarction
ST-elevation acute myocardial infarction 0.270
Yes 1990 (69.1%) 891 (30.9%)
No 2546 (67.8%) 1209 (32.2%)
Ejection fraction <40% 0.001
Yes 875 (65.1%) 470 (34.9%)
No 3018 (69.8%) 1308 (30.2%)
Missing 643 322
Killip class 0.399
I 3719 (68.7%) 1693 (31.3%)
II 419 (66.0%) 216 (34.0%)
III 79 (66.9%) 39 (33.1%)
IV 37 (62.7%) 22 (37.3%)
Unknown 282 130
Diseased vessels 0.006
0 399 (73.2%) 146 (26.8%)
1 1854 (69.6%) 810 (30.4%)
2 988 (66.5%) 497 (33.5%)
3 863 (66.3%) 438 (33.7%)
Missing 432 209
Revascularization type 0.974
None 1241 (68.2%) 579 (31.8%)
Percutaneous coronary intervention 2835 (68.4%) 1311 (31.6%)
Coronary artery bypass graft surgery 460 (68.7%) 210 (31.3%)
Acute systolic blood pressure 141.7 ± 31.0 141.5 ± 30.1 0.725
Missing 60 30
Initial heart rate 81.7 ± 21.6 83.1 ± 22.5 0.022
Missing 45 22
GRACE 6-month mortality risk score 101.3 ± 30.5 106.0 ± 31.8 <0.001
Percent of eligible QOC indicators received 0.252
0 - <90 1556 (67.5%) 750 (32.5%)
90 - 100 2975 (68.8%) 1346 (31.2%)
Missing 5 4

Continuous variables compared using Student's t-test; categorical variables compared using chi-square or Fisher exact test.

ENRICHD, Enhancing Recovery in Coronary Heart Disease Patients; GRACE, Global Registry of Acute Coronary Events; PHQ, Patient Health Questionnaire; QOC, quality of care

COMMENT

More than two-thirds of AMI patients indicated a preference to play an active role in the decision-making process, and of those, about a quarter preferred that the decision be theirs alone, rather than shared with their doctor. In addition, demographic and clinical characteristics did not predict well who preferred an active role. The results of this study highlight that a great majority of patients want to be involved in decision-making, while also showing that there is a marked minority of patients who would prefer to be passive.

While some studies used hypothetical situations to assess decision-making preferences, we directly elicited patients’ preferences at the time that decisions were being made. The predictive model had limited discrimination. Our findings indicate that physicians who aspire to provide patient-centered care should assess patients’ decision-making preferences by directly asking each patient.

A potential limitation of this study is the approach we used to elicit patient decision-making responses. We may have failed to capture the full scope of patient preferences, and mixed-methods studies may reveal nuances to these preferences that are not readily apparent in a fixed-response question.

Decision-making preferences vary among patients after an AMI, but many patients prefer an active style. To know a patient's preference requires a specific conversation. Our challenge now is to develop systems that fully respect these preferences and ensure that patients who prefer an active role are given that opportunity.

ACKNOWLEDGMENT

We gratefully acknowledge Vishnu Patlolla, Gregory Mulvey, and Marian Mocanu for their contributions, which were provided without compensation.

Sources of Funding: The TRIUMPH study was supported by grant P50 HL077113 from the Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease from the National Heart, Lung, and Blood Institute in Bethesda, Maryland. PREMIER was funded by CV Therapeutics, Inc., Palo Alto, California. This study was also funded in part by CV Outcomes, Inc., Kansas City, Missouri. During the time that this work was conducted, Dr. Barreto-Filho was a postdoctoral fellow at Yale University supported by grant 3436-10-1 from CAPES (Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Ministry of Education, Brazil). Dr. Spertus has been funded by the National Heart, Lung, and Blood Institute in Bethesda, Maryland, the American Heart Association in Dallas, Texas, and the American College of Cardiology Foundation in Washington, District of Columbia. Dr. Krumholz is funded by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute in Bethesda, Maryland.

Role of the Sponsors: The funding sponsors had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.

Footnotes

Author Contributions:

Study concept and design: Krumholz, Spertus

Acquisition of data: Krumholz, Spertus

Analysis and interpretation of data: Barreto-Filho, Jones, Krumholz, Li, Spertus

Drafting of the manuscript: Krumholz

Critical revision of the manuscript for important intellectual content: Barreto-Filho, Jones, Krumholz, Li, Spertus

Statistical analysis: Jones, Li

Obtained funding: Krumholz, Spertus

Administrative, technical, or material support: N/A

Study supervision: Krumholz, Spertus

Conflict of Interest Disclosure:

Dr. Krumholz chairs a cardiac scientific advisory board for UnitedHealth and is the recipient of a research grant, through Yale University, from Medtronic. Dr. Spertus has received grant support from Lilly, Genentech, and EvaHeart. He serves on a cardiac scientific advisory board for UnitedHealth, and as a consultant to Genentech, Amgen, and St. Jude Medical. He has an equity position in Health Outcomes Sciences and owns the copyright to the Seattle Angina Questionnaire, Kansas City Cardiomyopathy Questionnaire, and Peripheral Artery Questionnaire.

Data Access and Responsibility:

Mr. Jones and Dr. Li had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

References

  • 1.Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–1952. doi: 10.1161/CIR.0b013e31824f2173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Walsh MN, Bove AA, Cross RR, et al. ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee. J Am Coll Cardiol. 2012;59(23):2125–2143. doi: 10.1016/j.jacc.2012.03.016. [DOI] [PubMed] [Google Scholar]
  • 3.Arnold SV, Chan PS, Jones PG, et al. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry. Circ Cardiovasc Qual Outcomes. 2011;4(4):467–476. doi: 10.1161/CIRCOUTCOMES.110.960468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Spertus JA, Peterson E, Rumsfeld JS, Jones PG, Decker C, Krumholz H. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomes. Am Heart J. 2006;151(3):589–597. doi: 10.1016/j.ahj.2005.05.026. [DOI] [PubMed] [Google Scholar]
  • 5.Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med. 1996;156(13):1414–1420. [PubMed] [Google Scholar]

RESOURCES